Skip to main content
Will Clifton, MD, Pediatrics, Houston, TX

WillCliftonMD

Pediatrics • Houston, TX

PGY-1

Join to view full profile

Dr. Clifton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Clifton's full profile

Already have an account?

  • Office

    1 Baylor Plaza
    Houston, TX 77030

Education & Training

  • Baylor College of Medicine (Houston)
    Baylor College of Medicine (Houston)Residency, Pediatrics, 2024 - 2027
  • Baylor College of Medicine
    Baylor College of MedicineClass of 2012

Awards, Honors, & Recognition

  • Engineering Faculty Teaching Award Rice University, 2020

Publications & Presentations

PubMed

Other

  • US Patent 11351359: Support structures for intravascular blood pumps. 
    Clifton W, Earles R, Hertzog B, Heuring J, Durst C, Benavides O, Fain E.
    6/7/2022
  • US Patent 11235138: Non-occluding intravascular blood pump providing reduced hemolysis. 
    Groß-Hardt S, Kaufmann T, Clifton W, Hertzog B, Heuring J.
    2/1/2022
  • US Patent 9572915: Systems and methods for fluid flows and/or pressures for circulation and perfusion enhancement. 
    Heuring J, Clifton W, Hertzog B, Cuchiara M, Delgado R.
    2/21/2017

Press Mentions

  • Reducing Economic Burden of Cardiorenal Syndrome with Aortix Pump
    Reducing Economic Burden of Cardiorenal Syndrome with Aortix PumpApril 29th, 2019

Grant Support

  • Development of a Polymeric Percutaneous Pulmonary Valve for Use in Young ChildrenNIH NHLBI2021–2022

Industry Relationships

  • COO, PolyVascularPolyvascular is developing a polymeric, percutaneous heart valve to reduce surgeries for kids with congenital heart disease. We raised $6M during my time at PolyVascular, where I served as Principal Investigator for a $2.5M Phase II NIH SBIR grant.Disclosure: Consultant, Equity2020 - 2024
  • Director, Medical Innovation; Lecturer, Rice UniversityRan and taught the medical innovation masters program in Biomedical Engineering (MBE)2018 - 2020
  • Sr Director, Medical Affairs, ProcyrionAortix is a percutaneous mechanical circulatory support (pMCS) device designed to treat heart failure patients who are too sick for medication alone. I developed the clinical and regulatory strategy and worked on the early pump and delivery system designs, ran pre-clinical and first in human studyDisclosure: Equity2012 - 2018

External Links

  • LinkedInhttp://linkedin.com/in/wclifton1/

Dr. Will Clifton, Dr. Will Clifton, MD, Dr. W Clifton